Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Vaccinations01:51

Vaccinations

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of the COVID-19 Pandemic on HPV Vaccination in Low- and Middle-Income Countries: A Scoping Review.

Vaccines·2026
Same author

Predictive Value of 2D Phase Contrast Magnetic Resonance Imaging in Patients with Suspected Chronic Mesenteric Ischemia.

Annals of vascular surgery·2026
Same author

Prenatal Care Barriers Among Immigrant Women in Canada: A Scoping Review.

Maternal and child health journal·2026
Same author

Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement risk.

Nature communications·2025
Same author

Macromolecular dimensions of a synthetic polyelectrolyte as a factor in its interactions with protein and cells: desirability for longer chains.

Journal of materials chemistry. B·2025
Same author

Polyphosphazene-Mediated Assembly of TLR4 and TLR7/8 Agonists Enables a Potent Nano-Adjuvant Delivery System for Hepatitis C Virus Vaccine Antigens.

Vaccines·2025
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

Intradermal immunization using coated microneedles containing an immunoadjuvant.

Alexander K Andrianov1, George Mutwiri

  • 1Apogee Technology, Inc., 129 Morgan Drive, Norwood, MA 02062, United States. aandrianov@verizon.net

Vaccine
|June 12, 2012
PubMed
Summary
This summary is machine-generated.

Microneedle technology enhances intradermal immunization, but formulation challenges exist. Synthetic biomaterials like PCPP show promise as microfabrication agents and potent immunoadjuvants for improved vaccine delivery.

More Related Videos

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery
06:37

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery

Published on: October 18, 2012

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Related Experiment Videos

Last Updated: May 21, 2026

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery
06:37

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery

Published on: October 18, 2012

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Area of Science:

  • Vaccinology
  • Biomaterials Science
  • Nanotechnology

Background:

  • Intradermal immunization offers potential for new vaccine development and global access.
  • Microneedle technology advances this approach but presents formulation challenges, particularly regarding immunoadjuvant compatibility.
  • Existing and emerging immunoadjuvants require careful consideration for microneedle-based vaccine delivery.

Purpose of the Study:

  • To review immunoadjuvant-enhanced microneedle immunization.
  • To explore the potential of synthetic biomaterials in microneedle vaccine formulations.
  • To highlight polyphosphazene macromolecular compounds (PCPP) as multifunctional agents.

Main Methods:

  • Literature review of intradermal immunization and microneedle technology.
  • Analysis of synthetic biomaterials for vaccine formulation.
  • Discussion of PCPP's properties and potential applications.

Main Results:

  • Synthetic biomaterials can address formulation challenges in microneedle immunization.
  • PCPP exhibits potential as both a microfabrication agent and an immunoadjuvant.
  • Multifunctional materials are key to advancing microneedle vaccine technology.

Conclusions:

  • Synthetic biomaterials, exemplified by PCPP, can overcome limitations in microneedle-based vaccine delivery.
  • PCPP offers a dual role in microneedle fabrication and immune enhancement.
  • Further research into multifunctional biomaterials is crucial for next-generation vaccines.